Eric Brandt - 12 Apr 2024 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 Apr 2024, 19:08:50 UTC
Prior SEC filing
16 Jan 2024
Next SEC filing
17 May 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Dane Baumgardner, Attorney-In-Fact for Eric K. Brandt

Key filing fact

Eric Brandt filed Form 4 for DENTSPLY SIRONA Inc. (XRAY) on 15 Apr 2024.

Key facts

  • This page summarizes Eric Brandt's Form 4 filing for DENTSPLY SIRONA Inc. (XRAY).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 15 Apr 2024, 19:08.

Change

  • Previous filing in this sequence was filed on 16 Jan 2024.
  • Current net transaction value: +$246.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XRAY transaction

Common Stock

Award

Transaction value
$0
Shares
+73
Change %
+0.14%
Price
$0.000000
Shares after
53,372
Date
12 Apr 2024
Ownership
Direct
Footnotes
F1
XRAY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,400
Date
12 Apr 2024
Ownership
By The Brandt Family Trust U/a Dtd 06/09/2006

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

XRAY transaction Derivative

Phantom Stock (Directors' Deferred Compensation) DDC

Award

Transaction value
$246
Shares
+8
Change %
+0.51%
Price
$31.45
Shares after
1,543
Date
12 Apr 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8
Exercise price
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

Footnote F2

Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director.

Footnote F3

Comprised of phantom stock acquired as a result of accrued dividends.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .